Regard
regard.com
AI that analyzes patient records for diagnoses.
Quick Information
- Category:
- Healthcare
- Pricing:
- Contact Sales
- Platforms:
- Web, EHR integrations
- Free Plan:
- No
- Last Verified:
- October 2026
What Is Regard?
Regard is an AI clinical insights company selling to hospitals and health systems. Its software connects to the EHR, reads a patient's history and flags possible diagnoses for clinicians to review. After the clinician accepts a suggestion, Regard helps make sure the documentation is complete and accurate in a standard format, which matters for both clinical quality and hospital revenue. The company says it partners with Epic and Cerner.
Results reported by the company are bold. Since launching in 2021, Regard says its technology has surfaced more than three million diagnoses to care teams and generated more than $50 million in incremental revenue for partners such as Banner Health and Sentara. Those are vendor figures, not independent audits. Regard, formerly HealthTensor, raised a $5 million seed in 2021, a $15.3 million Series A in 2022 led by Calibrate Ventures and Foundry Group, and a $61 million Series B in July 2024 led by Oak HC/FT with Cedars-Sinai Health Ventures. TechCrunch reported a $350 million valuation at that time. The money is meant to fund core platform development, research into large language models and a move beyond inpatient settings. Pricing is not public, and nothing newer than 2024 turned up.
Regard suits hospitals that want to improve documentation completeness and catch missed diagnoses. Related tools in the Healthcare tools directory include Innovaccer, Glass Health and Abridge.
What Can You Use Regard For?
Diagnosis surfacing
Flags possible diagnoses from the patient's record.
Documentation completeness
Helps produce complete, standardized documentation.
Revenue integrity
Better documentation can raise appropriate reimbursement.
Regard Features
- EHR integration — Works inside the clinician's existing record.
- AI record review — Evaluates patient history to propose diagnoses.
- Clinician review step — Suggestions are accepted or rejected by clinicians.
- Enterprise partners — Banner Health and Sentara are named by the company.
Who Is Regard For?
- Hospitals and health systems — Improve documentation and catch missed diagnoses.
- Clinical documentation teams — Reduce manual chart review.
Regard Pros & Limitations
What We Like
- Works within the EHR
- Keeps clinicians in control of every suggestion
- Backed by healthcare-focused investors
Limitations
- Impact figures are company-reported
- No public pricing
- Latest funding news found was from 2024
Regard Pricing
| Plan | Price | Main Features |
|---|---|---|
| Enterprise | Custom | EHR-integrated clinical insights and documentation support |
Pricing was last verified October 2026. Check the official website for the latest pricing.
AI Listing Jungle Ranking
- Global Rank:
- #298
- Overall Score:
- 71.6/100
- Monthly Users:
- –
- Rank Change:
- ▼ 82
This ranking reflects AI Listing Jungle's own independent scoring methodology and is not an endorsement by Regard or its company. How Our Rankings Work
Frequently Asked Questions
What does Regard do?
It analyses patient records in the EHR and flags possible diagnoses for clinician review.
Who invests in Regard?
Its $61M Series B in July 2024 was led by Oak HC/FT with Cedars-Sinai Health Ventures.
What results does it claim?
More than three million diagnoses surfaced and over $50 million in incremental revenue for partners; these are company figures.
How much does it cost?
Pricing is not public.
Our Take
Regard tackles a real gap: diagnoses that sit in the chart but never reach the documentation. Keeping clinicians in the loop is the right design.
Treat the revenue numbers as marketing and ask for peer references.
Regard Alternatives
Regard Comparisons
Ready to try Regard?
Visit the official website to get started.
Visit Official WebsiteAI Listing Jungle is an independent AI tools directory. Product names, logos, and trademarks belong to their respective owners.